Drewinko B, Loo T L, Gottlieb J A
Cancer Res. 1976 Feb;36(2 Pt 1):511-5.
The cellular effects of three nitrosourea derivatives were investigated on a human lymphoma cell line. The three drugs show similar threshold-type dose-response survival curves on asynchronous cells treated for 1 hr. Longer incubation periods result in rapid biological degradation for 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, whereas, 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl)-1-nitrosourea, remains cytotoxic after about 24 hr. Important differences were noted with respect to cell cycle dependency. The 1,3-bis(2-chloroethyl)-1-nitrosourea was more effective in early S and in G2 phase, whereas both 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea and 1-(2-chloroethyl)-3-trans-4-methylcyclohexyl)-1-nitrosourea were more effective in early S. 1,3-bis(2-chlrorethyl)-1-nitrosourea exerted a considerable degree of killing in G1. Cells were unable to recover from priming damage induced by all 3 nitrosourea derivatives. No synergistic effects were observed in combination with vitamin A.
研究了三种亚硝基脲衍生物对一种人淋巴瘤细胞系的细胞效应。这三种药物对经1小时处理的异步细胞呈现相似的阈值型剂量反应存活曲线。较长的孵育期会导致1,3 - 双(2 - 氯乙基)- 1 - 亚硝基脲和1 - (2 - 氯乙基)- 3 - 环己基 - 1 - 亚硝基脲迅速发生生物降解,而1 - (2 - 氯乙基)- 3 - 反式 - 4 - 甲基环己基)- 1 - 亚硝基脲在约24小时后仍具有细胞毒性。在细胞周期依赖性方面观察到了重要差异。1,3 - 双(2 - 氯乙基)- 1 - 亚硝基脲在S期早期和G2期更有效,而1 - (2 - 氯乙基)- 3 - 环己基 - 1 - 亚硝基脲和1 - (2 - 氯乙基)- 3 - 反式 - 4 - 甲基环己基)- 1 - 亚硝基脲在S期早期更有效。1,3 - 双(2 - 氯乙基)- 1 - 亚硝基脲在G1期具有相当程度的杀伤作用。细胞无法从所有三种亚硝基脲衍生物诱导的引发损伤中恢复。与维生素A联合使用未观察到协同效应。